| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |